Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Declines By 99.6%

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,800 shares, a decline of 99.6% from the February 28th total of 499,900 shares. Based on an average daily volume of 7,236,000 shares, the days-to-cover ratio is currently 0.0 days.

Enzolytics Stock Up 16.7 %

Shares of OTCMKTS ENZC traded up $0.00 during trading on Wednesday, reaching $0.00. 252,908 shares of the stock traded hands, compared to its average volume of 5,156,214. Enzolytics has a 52-week low of $0.00 and a 52-week high of $0.01.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.